Vertellus

Vertellus operates through Aurorium India Private Limited (active). Its filings, financials, charges and directors are on the company page.

Vertellus has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arsenal Capital Partners, Wind Point Partners and Pritzker Private Capital.

All

Venture Fund

Investor	Description	Founded Year	Domain	Location
Arsenal Capital Partners	Private equity investments target specialty industrials and healthcare sectors.	2000	arsenalcapital.com	New York, United States
Wind Point Partners	A private equity firm focused on middle market businesses.	1984	wppartners.com	Chicago, United States
Pritzker Private Capital	Pritzker Private Capital is focused on partnering with middle-market companies.		ppcpartners.com	Chicago, United States

Premium access

Investor details for Vertellus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

• Complete investor list
• Round participation
• Investor portfolios
• Co-investor network

Access investors

Verified entity values are shown only after access is granted.

Aurorium India Private Limited is the primary company behind Vertellus. The board of Aurorium India Private Limited currently have 5 directors; the longest-serving is Tabassum Ruwabali Khan, appointed in 2015. 23 earlier directors have ceased.

28 people are tracked at Vertellus (8 in leadership, 20 in team); the tracked headcount is 63.

8 more people are available in the full profile.

Figures of Aurorium India Private Limited, the primary company behind Vertellus, for FY 2025. Revenue was ₹107 Cr (-25% year on year). Net profit was ₹15.65 Cr (15% margin). EBITDA was ₹26.09 Cr (24% margin). Revenue has grown at a compounded annual rate of -11% over three years and -5% over five years.

• ₹107 CrRevenue · FY 2025 · -25% YoY
• ₹15.65 CrNet profit · 15% margin
• ₹26.09 CrEBITDA · 24% margin
• ₹14.86 CrPaid-up capital
• 63Employees (provident fund records)
• -11%Revenue CAGR, 3 years
• -5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aurorium India Private Limited are on its company page.

Vertellus has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aurorium, JARCHEM and Pentagon Chemicals.

9 dated milestones of Vertellus across 165 years, from founding to its latest funding, stage changes and deals.

1. 1857 Founded Vertellus is founded.
2. Jul 2006 Exit Acquired by Arsenal Capital Partners.
3. Dec 2007 Exit Acquired by Wind Point Partners.
4. Nov 2014 Acquisition Acquires Pentagon Chemicals.
5. Nov 2014 Acquisition Acquires Pentagon Chemicals.
6. Jan 2020 Acquisition Acquires Aurorium.
7. Jan 2021 Exit Acquired by Pritzker Private Capital.
8. Dec 2021 Acquisition Acquires JARCHEM.
9. Feb 2022 Acquisition Acquires Aurorium.

Websites that share an audience with Vertellus (vertellus.com).

Websites whose visitors overlap most with Vertellus. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
EXTOL, Inc.	extolinc.com	100%		#3,023,127	View details
Woodward	woodward.com	66%	83.5K	#543,744	View details
Plascore	plascore.com	66%		#3,406,150	View details
Consumers Energy	consumersenergy.com	66%	2.1M	#23,057	View details
zfsinc.com	zfsinc.com	66%		#5,083,309	–

3 companies that operate in the same segment as Vertellus (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Indegene	Suite solutions are provided for payers and healthcare providers.	1998	Princeton, New Jersey, United States	USD 220 M	USD 374.1 M	4,490
Insulet	Wearable insulin infusion systems are developed for diabetes patients.	2000	Boston, Massachusetts, United States	USD 120.4 M	USD 2.71 B	3,900
MannKind Corp	Developer of small-molecule drugs	1991	Los Angeles, California, United States	USD 50 M	USD 348.97 M	407